Raynaud's Phenomenon Clinical Trial
Official title:
Monocenter, IIT, Open Controlled and Prospectiv Study to Define the Prognostic Influence of Light Rheography Measurement of Patients With Secundary Raynaud Syndrome With Ulcers at Fingertips Throughout the Medicinal Therapy
The purpose of this study is to evaluate the prognostic influence of light rheography measurement at the fingertips from subjects with secundary Raynaud syndrome.
Digital Ulcers (DU) belong to one of the most prevalent complications of systemic scleroses, leading in course to considerable impairment in everyday and professional life. The aetiology of the emergence of DU in patients with systemic scleroses (SSc) is complex, whereas the disease itself is primarily characterized by a vasculopathy of the small arterial vessels. In the course of the disease this chronic infection leads to fibrotic intimal hyperplasia, adventitial fibrosis, and thus to a significant lumen narrowing. So far, a number of independent risk factors have been identified, such as male gender, chronic infections of the esophagus, pulmonary-arterial hypertension, evidence of specific antibodies (e.g. anti-Scl70) in the blood, or the a previous manifestation of a Raynoud Syndrom. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00946738 -
The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis
|
N/A | |
Completed |
NCT02050360 -
"As Required" Oral Sildenafil in Raynaud's Phenomenon
|
Phase 2/Phase 3 | |
Completed |
NCT01117298 -
A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
|
Phase 3 | |
Completed |
NCT02583789 -
Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
|
Early Phase 1 | |
Terminated |
NCT01315899 -
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
|
Phase 2 | |
Completed |
NCT03058887 -
The Effects of Exercise in Patients With Systemic Sclerosis
|
N/A | |
Completed |
NCT00700518 -
Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
|
Phase 1 | |
Completed |
NCT02506062 -
A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
|
N/A | |
Completed |
NCT00841594 -
MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison
|
Phase 1 |